Authors: SHARMA A SLUGG PH HAMMETT JL JUSKO WJ

Citation: A. Sharma et al., ESTIMATION OF ORAL BIOAVAILABILITY OF A LONG HALF-LIFE DRUG IN HEALTHY-SUBJECTS, Pharmaceutical research, 15(11), 1998, pp. 1782-1786

Authors: SALAZAR DE MUCH DR NICHOLA PS SEIBOLD JR SHINDLER D SLUGG PH

Citation: De. Salazar et al., A PHARMACOKINETIC-PHARMACODYNAMIC MODEL OF D-SOTALOL Q-TC PROLONGATION DURING INTRAVENOUS ADMINISTRATION TO HEALTHY-SUBJECTS, Journal of clinical pharmacology, 37(9), 1997, pp. 799-809

Authors: GEHR TWB SICA DA SLUGG PH HAMMETT JL RAYMOND R FORD NF

Citation: Twb. Gehr et al., THE PHARMACOKINETICS OF PRAVASTATIN IN PATIENTS ON CHRONIC-HEMODIALYSIS, European Journal of Clinical Pharmacology, 53(2), 1997, pp. 117-121

Authors: MUCH DR SLUGG PH GRAVES TS UDERMAN HD

Citation: Dr. Much et al., EFFECTS OF D-SOTALOL AND D,L-SOTALOL ON ISOPROTERENOL-INDUCED INCREASES IN HEART-RATE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 168-168

Authors: SLUGG PH MUCH DR GRAVES TS UDERMAN HD

Citation: Ph. Slugg et al., PHARMACOKINETICS OF D-SOTALOL (DS) AND L-SOTALOL (LS) ADMINISTERED ASDS AND D,L-SOTALOL (DLS), Clinical pharmacology and therapeutics, 57(2), 1995, pp. 168-168

Authors: SLUGG PH HAUG M

Citation: Ph. Slugg et M. Haug, RANITIDINE PHARMACOKINETICS AND CENTRAL-NERVOUS-SYSTEM - REPLY, Archives of internal medicine, 154(3), 1994, pp. 343-347